Fund Name | Location |
Achar Ventures | - |
Antecedent Ventures | New York, New York, United States |
Bibby Financial Services | Georgia, Kennesaw, United States |
CatalyzeCU | Boulder, Colorado, United States |
EDB New Ventures | Central, Central Region, Singapore |
EPF Partners | France, Ile-de-France, Paris |
Five Elms Capital | Kansas City, Missouri, United States |
Grassfed Ventures | Canada, Ontario, Toronto |
Guangdian Capital | Beijing, Beijing, China |
Joe Fresh | Canada, Ontario, Ottawa |
L Marks | England, London, United Kingdom |
Mori Trust | Japan, Tokyo |
Netinvest | - |
Rohatton | - |
Sawaya Partners | New York, New York, United States |
Shaoxing Junhe Touzi Youxian Gongsi | China, Shaoxing, Zhejiang |
Veho | Finland, Southern Finland, Vantaa |
Xinronbang Asset Management | China, Fujian, Xiamen |
ZGI Capital | Latvia, Riga, Vidzeme |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Eleos Health | $40M | 08 Nov 2023 | Cambridge, Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Eleos Health | $40M | 08 Nov 2023 | Cambridge, Massachusetts, United States |